Classification, diagnosis, and differential diagnosis of multiple sclerosis

IK Sand - Current opinion in neurology, 2015 - journals.lww.com
Current multiple sclerosis phenotypic classifications include relapsing-remitting multiple
sclerosis, clinically isolated syndrome, radiologically isolated syndrome, primary …

Clinically isolated syndromes

DH Miller, DT Chard, O Ciccarelli - The Lancet Neurology, 2012 - thelancet.com
Clinically isolated syndrome (CIS) is a term that describes a first clinical episode with
features suggestive of multiple sclerosis (MS). It usually occurs in young adults and affects …

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

M Tintore, À Rovira, J Río, S Otero-Romero… - Brain, 2015 - academic.oup.com
Natural history studies have identified factors that predict evolution to multiple sclerosis or
risk of disability accumulation over time. Although these studies are based on large …

Vitamin D as an early predictor of multiple sclerosis activity and progression

A Ascherio, KL Munger, R White, K Köchert… - JAMA …, 2014 - jamanetwork.com
Importance It remains unclear whether vitamin D insufficiency, which is common in
individuals with multiple sclerosis (MS), has an adverse effect on MS outcomes. Objectives …

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

LK Fisniku, PA Brex, DR Altmann, KA Miszkiel… - Brain, 2008 - academic.oup.com
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord
syndromes are frequently the first clinical presentations of multiple sclerosis. However, not …

Differential diagnosis of suspected multiple sclerosis: a consensus approach

DH Miller, BG Weinshenker, M Filippi… - Multiple Sclerosis …, 2008 - journals.sagepub.com
Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of
diseases that could better explain the clinical and paraclinical findings. A systematic process …

The mechanism of action of interferon-β in relapsing multiple sclerosis

BC Kieseier - CNS drugs, 2011 - Springer
Multiple sclerosis (MS) is characterized by autoimmune inflammation and subsequent
neurodegeneration. It is believed that early in the disease course, proinflammatory T cells …

Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial

C Lebrun-Frénay, A Siva, MP Sormani… - JAMA …, 2023 - jamanetwork.com
Importance Radiologically isolated syndrome (RIS) represents the earliest detectable
preclinical phase of multiple sclerosis (MS) punctuated by incidental magnetic resonance …

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 …

L Kappos, MS Freedman, CH Polman, G Edan… - The Lancet …, 2009 - thelancet.com
Summary Background The Betaferon/Betaseron in newly emerging multiple sclerosis for
initial treatment (BENEFIT) trial investigated the effect of treatment with interferon beta-1b …

Multiple sclerosis relapses: epidemiology, outcomes and management. A systematic review

T Kalincik - Neuroepidemiology, 2015 - karger.com
Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature
of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. While their …